risk
hev
infect
schizophrenia
unknown
present
result
show
seropreval
antihev
igg
antihev
igm
schizophrenia
significantli
higher
healthi
control
antihev
igg
posit
increas
age
durat
diseas
schizophrenia
patient
moreov
schizophrenia
patient
increas
tcell
ratio
higher
antihev
igg
detect
rate
normal
ratio
compar
schizophrenia
patient
test
antihev
igg
neg
level
cytokin
significantli
higher
cytokin
level
significantli
lower
antihev
igg
posit
five
schizophrenia
patient
antihev
igm
posit
four
elev
tcell
ratio
hev
rna
isol
one
four
patient
classifi
genotyp
antihev
igm
posit
detect
among
healthi
control
therefor
schizophrenia
patient
exhibit
higher
risk
hev
infect
control
hepat
e
viru
hev
nonenvelop
singl
positivestrand
rna
viru
famili
hepevirida
worldwid
distribut
hepat
e
caus
hev
import
publichealth
problem
mani
develop
countri
caus
sporad
acut
hepat
develop
countri
although
overal
mortal
hepat
e
less
gener
popul
reach
pregnant
women
third
trimest
hev
infect
four
document
rout
transmiss
waterborn
foodborn
bloodborn
vertic
transmiss
mother
child
epidemiolog
studi
indic
higher
preval
hev
antibodi
observ
elderli
peopl
live
rural
area
poor
sanit
moreov
isol
anim
strain
hev
exist
anim
speci
test
seroposit
antihev
igg
igm
indic
hepat
e
zoonot
diseas
schizophrenia
complex
mental
diseas
highli
herit
involv
interplay
genet
environment
factor
immun
system
abnorm
report
patient
schizophrenia
evidenc
increas
express
proinflammatori
cytokin
tcell
activ
high
level
autoantibodi
alter
circul
inflammatori
cytokin
interferonc
ifnc
reflect
function
help
type
reflect
function
help
type
also
observ
previou
studi
moreov
previou
result
suggest
imbal
shift
toward
system
schizophrenia
epidemiolog
studi
alreadi
shown
rate
hepat
b
hepat
c
viru
infect
patient
schizophrenia
five
time
higher
respect
estim
gener
popul
rate
howev
risk
hepat
e
viru
infect
schizophrenia
still
unknown
current
studi
found
detect
rate
hev
antibodi
schizophrenia
patient
much
higher
healthi
control
antihev
igg
posit
increas
age
durat
schizophrenia
moreov
schizophren
patient
increas
ratio
cell
higher
antihev
igg
detect
rate
normal
ratio
compar
patient
test
antihev
igg
neg
level
significantli
higher
level
significantli
lower
antihev
igg
posit
studi
carri
august
march
two
hundr
sixtynin
individu
schizophrenia
sz
enrol
present
studi
diagnosi
schizophrenia
base
criteria
defin
diagnost
statist
manual
mental
disord
fourth
edit
text
revis
dsmiv
tr
mini
intern
neuropsychiatr
interview
mini
version
dsm
use
screen
patient
schizophrenia
data
collect
patient
enrol
inpati
diagnos
depart
psychiatri
huaian
third
hospit
jiangsu
china
moreov
patient
free
acut
infect
allerg
reaction
least
two
week
prior
collect
serum
sampl
two
hundr
sixti
healthi
control
hc
randomli
recruit
age
year
gender
match
annual
health
examin
popul
subject
live
region
healthi
control
found
free
schizophrenia
screen
use
mini
test
moreov
inclus
criteria
healthi
control
absenc
psychiatr
autoimmun
disord
lack
histori
disord
among
immedi
famili
member
addit
healthi
control
declar
free
acut
infect
allerg
reaction
least
two
week
prior
collect
serum
sampl
studi
conform
declar
helsinki
approv
research
ethic
committe
huaian
third
hospit
follow
establish
guidelin
particip
provid
written
inform
consent
studi
procedur
explain
antihev
igg
igm
assay
use
commerci
immunoassay
elisa
kit
wantai
biopharmaceut
inc
beij
china
describ
previous
sensit
specif
present
assay
antihev
igg
detect
antihev
igm
detect
respect
brief
plate
precoat
recombin
hev
protein
incub
test
sera
well
reactiv
nonreact
control
min
wash
five
time
incub
human
antiiggor
antiigmhorseradish
peroxidas
conjug
incub
min
plate
wash
incub
room
temperatur
min
enzym
substrat
absorb
read
nm
cutoff
valu
determin
accord
manufactur
instruct
heparin
whole
blood
incub
fitc
pe
percp
analyz
fourcolor
flow
cytometri
use
fluorescenceactiv
cell
sorter
facscalibur
bectondickinson
mountain
view
ca
describ
elsewher
total
event
collect
lymphocyt
gate
use
morpholog
paramet
data
process
use
cellquest
pro
softwar
bectondickinson
analyz
use
summit
softwar
tcell
tcell
tcell
count
express
proport
pbmc
level
serum
ifnc
assay
use
commerci
avail
elisa
kit
yuanxiang
biotech
inc
shanghai
china
cytokin
assay
optim
standard
curv
establish
use
standard
procedur
brief
plate
precoat
antiifnc
captur
antibodi
plate
wash
incub
serial
dilut
standard
test
specimen
h
plate
wash
five
time
incub
appropri
biotinyl
detect
antibodi
h
wash
incub
min
streptavidinconjug
horseradish
peroxidas
reaction
develop
tetramethylbenzidineh
substrat
final
wash
assay
sampl
analyz
duplic
casecontrol
pair
analyz
plate
lower
limit
detect
ifnc
pgml
pgml
respect
hev
rna
isol
sequenc
analysi
total
rna
five
antihev
igmposit
sampl
well
neg
posit
control
extract
serum
use
trizol
reagent
invitrogen
shanghai
china
reversetranscrib
subject
nest
pcr
amplifi
region
describ
previous
limit
hevrna
detect
present
assay
copiesml
copiesreact
purif
use
qiaquick
gel
extract
kit
qiagen
valencia
ca
usa
pcr
product
sent
invitrogen
sequenc
use
abi
genet
analyz
genet
analysi
perform
mega
version
temp
az
usa
unpair
student
ttest
use
test
differ
sz
hc
group
continu
variabl
differ
qualit
variabl
compar
use
v
trend
v
test
twosid
pvalu
set
denot
statist
signific
statist
analysi
perform
use
statist
product
servic
solut
spss
spss
inc
chicago
usa
demograph
clinic
characterist
patient
control
shown
tabl
age
gender
differ
schizophrenia
patient
control
increas
level
alanin
aminotransferas
alt
aspart
aminotransferas
ast
detect
schizophrenia
patient
respect
six
patient
elev
level
alt
ast
hc
group
two
eight
individu
elev
level
alt
ast
respect
none
control
abnorm
level
alt
ast
sz
group
patient
show
activ
cell
increas
ratio
cell
eight
peopl
hc
group
increas
ratio
cell
tabl
signific
differ
found
sz
group
control
correl
detect
rate
gender
durat
ill
summar
tabl
ninetyfour
sz
group
posit
antihev
igg
peopl
hc
group
posit
p
patient
longer
cours
diseas
year
tend
show
higher
rate
posit
patient
less
year
diseas
p
detect
rate
hev
igg
antibodi
increas
age
sz
group
healthi
popul
signific
differ
male
femal
either
sz
hc
group
addit
five
case
four
male
one
femal
hev
igm
antibodi
posit
sz
group
individu
antihev
igm
posit
hc
group
p
level
serum
ifnc
measur
elisa
signific
differ
observ
serum
level
schizophrenia
patient
higher
valu
tcell
ratio
normal
valu
vs
vs
vs
differ
serum
ifnc
level
observ
vs
ifnc
comparison
schizophrenia
patient
test
hev
igg
neg
heviggposit
patient
level
serum
significantli
higher
level
serum
significantli
lower
p
p
p
respect
tabl
differ
level
serum
ifnc
heviggposit
neg
patient
moreov
differ
cytokin
level
observ
within
hc
group
regardless
hev
igg
statu
data
shown
five
antihevigmposit
sampl
one
sampl
increas
level
alt
ast
elev
tcell
ratio
posit
hev
rna
sequenc
pcr
product
sequenc
compar
known
hev
isol
isol
similar
genotyp
isol
similar
genotyp
hev
strain
respect
therefor
hev
isol
name
hevhuaiansz
genbank
classifi
genotyp
wide
distribut
china
studi
contribut
spars
literatur
hev
seroposit
schizophrenia
patient
previou
studi
higher
preval
antibodi
hbv
nucleocapsid
protein
seen
patient
psychiatr
disord
epidemiolog
studi
also
prove
patient
schizophrenia
significantli
like
infect
hcv
without
schizophrenia
moreov
higher
seropreval
antibodi
cytomegaloviru
herp
simplex
viru
human
immunodefici
viru
influenza
viru
coronavirus
found
psychot
patient
compar
gener
popul
therefor
reason
us
carri
present
studi
evalu
risk
hev
infect
patient
schizophrenia
result
confirm
hypothesi
antihev
igg
igm
detect
rate
schizophrenia
significantli
higher
healthi
control
sever
factor
could
contribut
higher
detect
rate
hev
antibodi
schizophrenia
patient
first
symptom
schizophrenia
particular
symptom
cognit
impair
may
contribut
directli
inabl
safeguard
transmiss
waterborn
foodborn
bloodborn
infect
second
schizophrenia
patient
usual
resid
set
psychiatr
facil
often
forg
social
relationship
higherrisk
individu
third
financi
instabl
poverti
also
associ
increas
risk
hev
infect
clinic
symptom
hepat
e
typic
selflimit
acut
viral
hepat
gener
sever
hepat
e
occur
elderli
pregnant
women
peopl
chronic
hepat
b
chronic
hepat
c
chronic
hepat
e
infect
also
document
patient
receiv
immunosuppress
therapi
follow
organ
transplant
infect
hiv
immun
respons
hev
involv
antibodymedi
immun
cellmedi
immun
interferon
host
defens
data
cellular
immun
respons
hev
suggest
tcell
count
significantli
higher
recov
hevinfect
individu
acut
infect
hev
patient
gener
popul
level
tcell
similar
group
schizophrenia
increas
level
cell
higher
tcell
ratio
document
previous
present
studi
detect
rate
antihev
igg
schizophrenia
patient
increas
tcell
ratio
significantli
higher
patient
normal
ratio
thu
welldesign
studi
carri
analyz
relationship
tcell
level
increas
risk
hev
infect
schizophrenia
patient
cellular
immun
respons
infect
either
type
character
cytokin
ifnc
type
character
cytokin
hepat
b
c
viru
infect
predomin
immun
respons
activ
liver
trauma
accord
pal
et
al
ifnc
cytokin
lower
hevinfect
pregnant
women
healthi
peopl
furthermor
product
cytokin
higher
hevinfect
pregnant
women
control
result
suggest
pregnant
women
acut
hev
infect
show
shift
balanc
toward
respons
shift
might
play
role
particularli
sever
clinic
cours
mortal
hev
infect
late
pregnanc
note
schizophrenia
might
also
associ
imbal
cytokin
also
shift
toward
system
present
studi
bia
observ
schizophrenia
patient
evidenc
increas
product
lower
product
moreov
signific
differ
serum
level
observ
among
schizophrenia
patient
without
hev
igg
antibodi
major
implic
studi
may
potenti
risk
factor
schizophrenia
patient
may
respons
increas
transmiss
hev
also
sever
limit
present
studi
first
variou
drug
use
schizophrenia
may
affect
immun
system
virtual
schizophrenia
patient
type
medic
relationship
drug
immun
bia
effect
relationship
risk
hev
infect
schizophrenia
assess
futur
second
includ
inflammatori
marker
serum
ifnc
thu
futur
work
care
interpret
light
third
larger
number
schizophrenia
patient
control
well
longterm
followup
requir
analyz
increas
risk
hev
infect
schizophrenia
taken
togeth
schizophrenia
patient
exhibit
higher
risk
hev
infect
control
present
studi
antihev
igg
seroposit
increas
age
durat
ill
moreov
schizophrenia
patient
increas
tcell
ratio
higher
antihev
igg
detect
rate
normal
ratio
level
significantli
higher
level
significantli
lower
schizophrenia
patient
antihev
igg
posit
antibodi
neg
order
understand
question
behind
observ
associ
work
need
larger
sampl
longitudin
followup
